Title
a. Authorize the Chief Executive Officer for Natividad Medical Center (NMC) or his designee to execute the business associate agreement (“BAA”) with PACSHealth, LLC for DoseMonitor software maintenance and support services at NMC with an agreement term November 12, 2024 through November 11, 2027. There is no cost associated with this agreement.
b. Approve the NMC’s Chief Executive Officer’s recommendation to accept non-standard indemnification provision within the business associate agreement.
Report
RECOMMENDATION:
It is recommended the Board of Supervisors:
a. Authorize the Chief Executive Officer for Natividad Medical Center (NMC) or his designee to execute the business associate agreement (“BAA”) with PACSHealth, LLC for DoseMonitor software maintenance and support services at NMC with an agreement term November 12, 2024 through November 11, 2027. There is no cost associated with this agreement.
b. Approve the NMC’s Chief Executive Officer’s recommendation to accept non-standard indemnification provision within the business associate agreement.
SUMMARY/DISCUSSION:
The DoseMonitor product will be replacing the Philips product that is no longer supported by Philips and will be terminated.
DoseMonitor will assist Natividad Medical Center in meeting and maintaining compliance with CDPH and Federal safety guidelines required for monitoring patient dose exposures. We are required to develop, document and implement a full radiation protection program in accordance with the use of ionizing radiation producing equipment.
DoseMonitor will allow us to use procedures and engineering controls based upon sound radiation protection principles to achieve doses to members of the public that are as low as is reasonably achievable (ALARA) and document procedures addressing this requirement. Natividad Medical Center is responsible for ensuring that the public is protected and that the public dose does not exceed the limits found in 10 CFR 20 of the nuclear regu...
Click here for full text